Screener
Emergent Biosolutions EBS Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
FAQ
- What is Emergent Biosolutions's interest expense?
- Emergent Biosolutions (EBS) reported interest expense of $10M in Q2 2026.
- How has Emergent Biosolutions's interest expense changed year-over-year?
- Emergent Biosolutions's interest expense decreased by 32.0% year-over-year, from $14.7M to $10M.
- What is the long-term trend for Emergent Biosolutions's interest expense?
- Over 4 years (2021 to 2025), Emergent Biosolutions's interest expense has grown at a 14.5% compound annual growth rate (CAGR), from $34.5M to $59.3M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Emergent Biosolutions's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude